| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
2019 American Thoracic Society International Conference
|
Venkatesan, Priya
|
|
|
7 |
9 |
p. 736
|
artikel
|
| 2 |
Biomarkers and early treatment of idiopathic pulmonary fibrosis
|
Kropski, Jonathan A
|
|
|
7 |
9 |
p. 725-727
|
artikel
|
| 3 |
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
|
Maher, Toby M
|
|
|
7 |
9 |
p. 771-779
|
artikel
|
| 4 |
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial
|
Pascoe, Steven
|
|
|
7 |
9 |
p. 745-756
|
artikel
|
| 5 |
Blood eosinophils as a continuous variable in the treatment of COPD: impact on the guidelines
|
van den Berge, Maarten
|
|
|
7 |
9 |
p. 722-723
|
artikel
|
| 6 |
Clean air in the ‘big smoke’
|
Ranscombe, Peter
|
|
|
7 |
9 |
p. 742-743
|
artikel
|
| 7 |
Correction to Lancet Respir Med 2019; 7: 402–16
|
|
|
|
7 |
9 |
p. e28
|
artikel
|
| 8 |
Correction to Lancet Respir Med 2019; 7: 733–35
|
|
|
|
7 |
9 |
p. e28
|
artikel
|
| 9 |
Efficacy of oral amoxicillin–clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial
|
Goyal, Vikas
|
|
|
7 |
9 |
p. 791-801
|
artikel
|
| 10 |
Ethnicity and spirometric indices: hostage to tunnel vision?
|
Agrawal, Anurag
|
|
|
7 |
9 |
p. 743-744
|
artikel
|
| 11 |
Finding the missing millions affected by tuberculosis is one thing; treating them is another
|
Cooper, Ashley
|
|
|
7 |
9 |
p. 741
|
artikel
|
| 12 |
How sustainable are new treatment strategies for NSCLC?
|
Remon, Jordi
|
|
|
7 |
9 |
p. 733-735
|
artikel
|
| 13 |
Inhaled hypertonic saline for 3–6-year-olds with cystic fibrosis
|
Southern, Kevin W
|
|
|
7 |
9 |
p. 730-732
|
artikel
|
| 14 |
Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial
|
Ratjen, Felix
|
|
|
7 |
9 |
p. 802-809
|
artikel
|
| 15 |
Insights and challenges in tuberculosis vaccine development
|
McShane, Helen
|
|
|
7 |
9 |
p. 810-819
|
artikel
|
| 16 |
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial
|
Tameris, Michele
|
|
|
7 |
9 |
p. 757-770
|
artikel
|
| 17 |
Negotiations between the NHS and Vertex on access to lumacaftor and ivacaftor become protracted
|
Burki, Talha Khan
|
|
|
7 |
9 |
p. 739-740
|
artikel
|
| 18 |
Preventing asthma deaths: above all, do no harm
|
Bush, Andrew
|
|
|
7 |
9 |
p. 732-733
|
artikel
|
| 19 |
Prospects and challenges of a new live tuberculosis vaccine
|
Achkar, Jacqueline M
|
|
|
7 |
9 |
p. 723-725
|
artikel
|
| 20 |
Pulmonary hypertension associated with idiopathic interstitial pneumonia: is effective pharmacotherapy an impossible dream?
|
Meyer, Keith C
|
|
|
7 |
9 |
p. 727-728
|
artikel
|
| 21 |
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study
|
Nathan, Steven D
|
|
|
7 |
9 |
p. 780-790
|
artikel
|
| 22 |
Scientists call for US EPA to reconvene expert panel on particulate matter pollution
|
Furlow, Bryant
|
|
|
7 |
9 |
p. 737-738
|
artikel
|
| 23 |
Small airways dysfunction: is there any involvement in patients with atopy?
|
Barbetta, Carlo
|
|
|
7 |
9 |
p. e26
|
artikel
|
| 24 |
Small airways dysfunction: is there any involvement in patients with atopy? – Authors' reply
|
Kraft, Monica
|
|
|
7 |
9 |
p. e27
|
artikel
|
| 25 |
Smoking cessation efforts should target LMICs
|
The Lancet Respiratory Medicine,
|
|
|
7 |
9 |
p. 721
|
artikel
|
| 26 |
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis
|
Dheda, Keertan
|
|
|
7 |
9 |
p. 820-826
|
artikel
|
| 27 |
What's BEST for children with non-cystic fibrosis bronchiectasis?
|
O'Sullivan, Brian
|
|
|
7 |
9 |
p. 729-730
|
artikel
|
Tijdschrift beschrijving